Which condition is NOT a labeled FDA indication for Ketoconazole?

Which condition is NOT a labeled FDA indication for Ketoconazole?

• A. Dandruff
• B. Tinea cruris
• C. Urinary tract infection
• D. Seborrheic dermatitis

Answer: (C)

Ketoconazole is an antifungal medication widely recognized for its effectiveness in treating various fungal and yeast infections. Among its labeled FDA indications are conditions like dandruff, tinea cruris (commonly known as jock itch), and seborrheic dermatitis. These conditions all involve infections or excessive growth of fungi that ketoconazole can effectively target. In contrast, the treatment of urinary tract infections (UTIs) is not included in the FDA indications for ketoconazole. UTIs are primarily caused by bacteria, and ketoconazole is not indicated for bacterial infections, which is why this answer is correct. Ketoconazole's mechanism of action involves inhibiting fungal cell membrane synthesis, making it unsuitable for addressing infections that originate from bacterial pathogens.

Ketoconazole is an antifungal medication widely recognized for its effectiveness in treating various fungal and yeast infections. Among its labeled FDA indications are conditions like dandruff, tinea cruris (commonly known as jock itch), and seborrheic dermatitis. These conditions all involve infections or excessive growth of fungi that ketoconazole can effectively target.

In contrast, the treatment of urinary tract infections (UTIs) is not included in the FDA indications for ketoconazole. UTIs are primarily caused by bacteria, and ketoconazole is not indicated for bacterial infections, which is why this answer is correct. Ketoconazole's mechanism of action involves inhibiting fungal cell membrane synthesis, making it unsuitable for addressing infections that originate from bacterial pathogens.